Suzana Buac1, Erik Schadde2, Andreas A Schnitzbauer3, Kelly Vogt1, Roberto Hernandez-Alejandro4. 1. Dept. of Surgery, Western University, London, ON, Canada. 2. Division of Transplantation, Dept. of Surgery, Rush University Medical Center, Chicago, IL, United States; Cantonal Hospital Winterthur, Winterthur, Canton Zurich, Switzerland. 3. Dept. of General and Visceral Surgery, Frankfurt/Main, Germany. 4. Dept. of Surgery, Western University, London, ON, Canada. Electronic address: roberto.hernandezalejandro@lhsc.on.ca.
Abstract
BACKGROUND: ALPPS was developed to induce accelerated future liver remnant (FLR) hypertrophy in order to increase hepatic tumour resectability and reduce the risk of post-operative liver failure. While early studies demonstrated concerning complication rates, others reported favourable results. This inconsistency may be due to variability in surgical indications and technique. METHODS: A web-based survey was sent to surgeons participating in the International ALPPS Registry in September of 2014. Questions addressed surgeon demographics and training, surgical indications and technique, and clinical management approaches. RESULTS: Fifty six out of 85 surgeons from 78 centers responded (66%) and half (n = 30) had training in liver transplantation. Forty seven (84%) did not reserve ALPPS solely for colorectal liver metastases (CRLM) and 30 (54%) would perform ALPPS for an FLR over 30%. Neoadjuvant chemotherapy for CRLM was recommended by 37 (66%) respondents. Surgical approaches varied considerably, with 30% not preserving outflow to the middle hepatic vein and 39% believing it necessary to skeletonize the hepatoduodenal ligament. Twenty five (45%) surgeons have observed segment 4 necrosis. CONCLUSION: There is considerable variability in how ALPPS is performed internationally. This heterogeneity in practice patterns may explain the current incongruity in published outcomes, and highlights the need for standardization.
BACKGROUND: ALPPS was developed to induce accelerated future liver remnant (FLR) hypertrophy in order to increase hepatic tumour resectability and reduce the risk of post-operative liver failure. While early studies demonstrated concerning complication rates, others reported favourable results. This inconsistency may be due to variability in surgical indications and technique. METHODS: A web-based survey was sent to surgeons participating in the International ALPPS Registry in September of 2014. Questions addressed surgeon demographics and training, surgical indications and technique, and clinical management approaches. RESULTS: Fifty six out of 85 surgeons from 78 centers responded (66%) and half (n = 30) had training in liver transplantation. Forty seven (84%) did not reserve ALPPS solely for colorectal liver metastases (CRLM) and 30 (54%) would perform ALPPS for an FLR over 30%. Neoadjuvant chemotherapy for CRLM was recommended by 37 (66%) respondents. Surgical approaches varied considerably, with 30% not preserving outflow to the middle hepatic vein and 39% believing it necessary to skeletonize the hepatoduodenal ligament. Twenty five (45%) surgeons have observed segment 4 necrosis. CONCLUSION: There is considerable variability in how ALPPS is performed internationally. This heterogeneity in practice patterns may explain the current incongruity in published outcomes, and highlights the need for standardization.
Authors: Erik Schadde; Victoria Ardiles; Ricardo Robles-Campos; Massimo Malago; Marcel Machado; Roberto Hernandez-Alejandro; Olivier Soubrane; Andreas A Schnitzbauer; Dimitri Raptis; Christoph Tschuor; Henrik Petrowsky; Eduardo De Santibanes; Pierre-Alain Clavien Journal: Ann Surg Date: 2014-11 Impact factor: 12.969
Authors: Martin de Santibañes; Fernando A Alvarez; Fanny Rodriguez Santos; Victoria Ardiles; Eduardo de Santibañes Journal: J Am Coll Surg Date: 2014-05-15 Impact factor: 6.113
Authors: Felice Giuliante; Francesco Ardito; Alessandro Ferrero; Luca Aldrighetti; Giorgio Ercolani; Gennaro Grande; Francesca Ratti; Ivo Giovannini; Bruno Federico; Antonio D Pinna; Lorenzo Capussotti; Gennaro Nuzzo Journal: J Am Coll Surg Date: 2014-04-13 Impact factor: 6.113
Authors: R Robles; P Parrilla; A López-Conesa; R Brusadin; J de la Peña; M Fuster; J A García-López; E Hernández Journal: Br J Surg Date: 2014-06-19 Impact factor: 6.939
Authors: Gregor A Stavrou; Marcello Donati; Mohammad H Fard-Aghaie; Martin Zeile; Tessa M Huber; Axel Stang; Karl J Oldhafer Journal: Visc Med Date: 2017-11-30
Authors: Jack Martin; Angelica Petrillo; Elizabeth C Smyth; Nadeem Shaida; Samir Khwaja; H K Cheow; Adam Duckworth; Paula Heister; Raaj Praseedom; Asif Jah; Anita Balakrishnan; Simon Harper; Siong Liau; Vasilis Kosmoliaptsis; Emmanuel Huguet Journal: World J Clin Oncol Date: 2020-10-24